Diabetes is a deep-seated disease affecting millions every year. The estimated global prevalence of diabetes is expected to increase from 171 million in 2000 to 366 million in 2030. The rise in the incidence of diabetes and longer disease duration is anticipated to change the disease profile particularly due to the development of complications. This will have a direct impact on people's quality of life, the need for medical services, and the cost of healthcare. The need for stringent lifestyle management, along with medical management makes the control of the disease challenging. Therefore, there exists a need for effective management strategies to control blood sugar levels and prevent complications.
Our team focuses on improving treatment outcomes in patients with diabetes and its complications. The research carried out includes the assessment of the cost-effectiveness of DPP4 inhibitors, a group of newer oral antidiabetic agents, and to assessment of the effectiveness of vitamin D supplementation as an adjunct therapy in the management and prevention of diabetic complications. We also work on the ADR monitoring and management of antidiabetic drugs.
We look forward or collaborating with researchers across the globe with common interests. Interested collaborators may contact at firstname.lastname@example.org.
Potential Ph.D. scholars who are interested to join to the group may contact email@example.com.
Acharya, Leelavathi D. Dr, "Diabetes Management" (2022). Health collection. 1.